FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

ncement document to version 2.0. Changes are highlighted throughout the document. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation

through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that